- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Cryopyrin-associated periodic syndromes (CAPS) is a rare hereditary inflammatory disorder that encompasses a continuum of three phenotypes: familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and neonatal multisystem inflammatory disease. Distinguishing features include cutaneous, neurologic, ophthalmologic, and rheumatologic manifestations.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
IL-1 beta |
Monoclonal Antibody |
Ilaris® |
150 mg/mL |
– |
4.5 mg |
-80°C |
2025.07 |
2.512,00 € |
||
IL-1 beta |
Monoclonal Antibody |
Ilaris® |
150 mg/mL |
– |
4.5 mg |
-80°C |
2025.07 |
2.512,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany